FDA Says Aware That Philips Ultrasound Has A Letter To Customers Recommending All Lumify Diagnostic Ultrasound Systems Have Updated Use Instructions; As Of Sept 29, Philips Ultrasound Reported 8 Serious Injuries, 4 Deaths Associated With Diagnostic Ultrasound System Issue

The FDA has acknowledged that Philips Ultrasound issued a letter to customers recommending updated use instructions for all Lumify Diagnostic Ultrasound Systems. As of September 29, Philips Ultrasound reported eight serious injuries and four deaths linked to issues with the diagnostic ultrasound system. This situation may impact the company's reputation and stock performance, particularly for the ticker PHG.